Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lisa Howell
Observed names:
Howell, L,
Howell, Lisa,
L. Howell
Institutions:
Alder Hey Children's NHS Foundation Trust,
Alder Hey Children's Hospital
Observed institutions:
National Health Service,
St. Jude Children's Research Hospital,
Alder Hey Children's NHS Foundation Trust,
Alder Hey Children's Hospital,
Royal Manchester Children's Hospital
ORCID:
0000-0003-2119-2630
Observed ORCID:
0000-0003-2119-2630
OpenAlex ID:
A5041539522
Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600–Mutant Pediatric High-Grade Glioma
2023
·
Darren R. Hargrave
, Keita Terashima
, et al.
·
Journal of Clinical Oncology
·
75
PDF
Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics—CheckMate 908
2023
·
Ira J Dunkel
, François Doz
, et al.
·
Neuro-Oncology
·
72
PDF
Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study
2022
·
Tanya Trippett
, Helen Toledano
, et al.
·
Targeted Oncology
·
44
PDF
Outcome of patients with stage IV high-risk Wilms tumour treated according to the SIOP2001 protocol: A report of the SIOP Renal Tumour Study Group
2020
·
Claudia Pasqualini
, Rhoikos Furtwängler
, et al.
·
European Journal of Cancer
·
44
PDF
DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition
2021
·
Elisa Izquierdo
, Diana M. Carvalho
, et al.
·
Cancer Discovery
·
36
PDF
International Comparisons of Clinical Demographics and Outcomes in the International Society of Pediatric Oncology Wilms Tumor 2001 Trial and Study
2022
·
Joaquim Caetano de Aguirre-Neto
, Beatriz de Camargo
, et al.
·
JCO Global Oncology
·
30
Wilms’ Tumor—Lessons and Outcomes—A 25-Year Single Center UK Experience
2014
·
David W. Fawkner-Corbett
, Lisa Howell
, et al.
·
Pediatric Hematology and Oncology
·
29
Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma
2024
·
Nathalie Gaspar
, Giun-Yi Hung
, et al.
·
JAMA Oncology
·
28
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial
2024
·
Lucas Moreno
, Rebekah Weston
, et al.
·
Journal of Clinical Oncology
·
28
Detection of recurrence in childhood solid tumors
2005
·
Lisa Howell
, Adjoa Mensah
, et al.
·
Cancer
·
28
Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature—A report from the SIOP Renal Tumor Study Group
2017
·
Janna A. Hol
, Marry M. van den Heuvel‐Eibrink
, et al.
·
Pediatric Blood & Cancer
·
20
Treatment of relapsed Wilms tumour (WT) patients: Experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG)
2014
·
A. M. C. Mavinkurve-Groothuis
, M. M. van den Heuvel-Eibrink
, et al.
·
Pediatric Blood & Cancer
·
16
PDF
Sertoli Leydig cell ovarian tumour and gastric polyps as presenting features of Peutz–Jeghers syndrome
2010
·
Lisa Howell
, Abdulgader Bader
, et al.
·
Pediatric Blood & Cancer
·
16
PDF
Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States
2024
·
Sally L. George
, Claire Lynn
, et al.
·
Cancer Discovery
·
13
PDF
Delphi method to identify expert opinion to support children’s cancer referral guidelines
2019
·
Matthew J Murray
, Amy Ruffle
, et al.
·
Archives of Disease in Childhood
·
13
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial
2025
·
Juliet C. Gray
, Rebekah Weston
, et al.
·
Journal of Clinical Oncology
·
12
Cervical paraganglioma—A case report and review of all cases reported to the Manchester Children's Tumour Registry 1954–2004
2006
·
Amarnath Challapalli
, Lisa Howell
, et al.
·
Pediatric Blood & Cancer
·
9
National advisory panels for childhood cancer in the United Kingdom: An evaluation of current practice and a best practice statement for the future
2022
·
Sarah Brown
, Tanzina Chowdhury
, et al.
·
Pediatric Blood & Cancer
·
8
PDF
Excision of extensive metastatic dysgerminoma to control refractory hypercalcaemia in a child at high risk for tumour-lysis syndrome
2011
·
Wajid Jawaid
, Valeria Solari
, et al.
·
Journal of Pediatric Surgery
·
8
Management of Ganglioneuroma and Ganglioneuroblastoma Intermixed: A United Kingdom Children's Cancer and Leukaemia Group (UK CCLG) Nationwide Study Report
2024
·
Katherine M. Burnand
, Jonathan Neville
, et al.
·
Pediatric Blood & Cancer
·
6
PDF
A phase 1 dose‐escalation study of LY3295668 erbumine as monotherapy and in combination with topotecan and cyclophosphamide in children with relapsed/refractory neuroblastoma
2025
·
Steven G. DuBois
, Chitose Ogawa
, et al.
·
Cancer
·
5
IMMU-08. Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: efficacy, safety, biomarker, and pharmacokinetic results from Checkmate 908
2022
·
Ira J Dunkel
, Kenneth Cohen
, et al.
·
Neuro-Oncology
·
3
Treatment of Relapsed Wilms Tumour (wt) Patients: Experience With Topotecan
2014
·
Mavinkurve-Groothuis, AMC
, Van den Heuvel - Eibrink, Marry
, et al.
·
EUR Research Repository (Erasmus University Rotterdam)
·
3
International comparisons of clinical demographics and outcomes in the SIOP Wilms tumour 2001 trial and study (2002-2011)
2019
·
Kathy Pritchard‐Jones
, Harm van Tinteren
, et al.
·
1
Ns-18role of Metformin in the Treatment of Hypothalamic Obesity Syndrome (hos)
2016
·
Arundoss Gangadharan
, Aliki Bogiatzopoulou
, et al.
·
Neuro-Oncology
·
1
Show more works
View as search
Works count:
102
Citation count:
548
H-index:
13
I10-index:
16
Year
Topic
Type